Post-Remission MRD Kinetics in Children with Acute Lymphoblastic Leukaemia Receiving Augmented BFM Consolidation Compared with Other Regimens Results of the Medical Research Council Trial UKALL2003.

অনুরূপ উপাদানগুলি

• Post-remission MRD kinetics in children with acute lymphoblastic leukaemia receiving augmented BFM consolidation compared with other regimens: update of results of the Medical Research Council Trial UKALL2003
  অনুযায়ী: Cutting, R, অন্যান্য
  প্রকাশিত: (2009)
• Genotype-specific MRD interpretation improves stratification in paediatric acute lymphoblastic leukaemia
  অনুযায়ী: O'Connor, D, অন্যান্য
  প্রকাশিত: (2017)
• Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood acute lymphoblastic leukaemia (ALL)
  অনুযায়ী: Moorman, A, অন্যান্য
  প্রকাশিত: (2007)
• Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
  অনুযায়ী: Vora, A, অন্যান্য
  প্রকাশিত: (2008)
• Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
  অনুযায়ী: Vora, A, অন্যান্য
  প্রকাশিত: (2014)